ACOR : Summary for Acorda Therapeutics, Inc. - Yahoo Finance

U.S. Markets close in 4 hrs 47 mins

Acorda Therapeutics, Inc. (ACOR)


NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
21.20+0.90 (+4.43%)
As of 11:13 AM EST. Market open.
People also watch:
AMAGALNYACADBMRNACHN
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close20.30
Open20.60
Bid21.10 x 300
Ask21.20 x 1000
Day's Range20.45 - 21.27
52 Week Range16.40 - 43.63
Volume70,716
Avg. Volume671,457
Market Cap977.62M
Beta1.29
PE Ratio (TTM)-42.06
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Is Kearny Financial (KRNY) A Good Stock To Buy?
    Insider Monkey3 days ago

    Is Kearny Financial (KRNY) A Good Stock To Buy?

    Billionaire hedge fund managers such as Steve Cohen and Stan Druckenmiller can generate millions or even billions of dollars every year by pinning down high-potential small-cap stocks and pouring cash into these candidates. Small-cap stocks are overlooked by most investors, brokerage houses, and financial services hubs, while the unlimited research abilities of the big players […]

  • Acorda Therapeutics Inc (ACOR) Continues To Fall From Favor With Top Investors
    Insider Monkey7 days ago

    Acorda Therapeutics Inc (ACOR) Continues To Fall From Favor With Top Investors

    Hedge funds run by legendary names like Nelson Peltz and David Tepper make billions of dollars a year for themselves and their super-rich accredited investors (you’ve got to have a minimum of $1 million liquid to invest in a hedge fund) by spending enormous resources on analyzing and uncovering data about small-cap stocks that the […]

  • Biotech Stock Roundup: Acorda Stops Ampyra PSWD Development, CRL for Spectrum's Qapzola
    Zacks12 days ago

    Biotech Stock Roundup: Acorda Stops Ampyra PSWD Development, CRL for Spectrum's Qapzola

    Focus is back on pipeline and regulatory updates with the end of the third quarter earnings season and elections.